Article

Docking Efficiency Comparison of Surflex, a Commercial Package and Arguslab, a Licensable Freewar

Journal of Computer Science & Systems Biology 01/2008;
Source: DOAJ

ABSTRACT Structure-based lead optimization approaches are increasingly playing a role in the drug-discovery process. Virtual screening by molecular docking has become a largely used approach to lead discovery in the pharmaceutical industry when a high-resolution structure of the biological target of interest is available. The performance of two docking programs (Arguslab and Surflex), for virtual database screening, is studied. Surflex is well recognizedcommercial package while Arguslab is distributed freely for Windows platforms by Planaria Software. Comparisons of these docking programs and scoring functions using a large and diverse data set of pharmaceutically interesting targets and active compounds are carried out. We focus on the problem of docking and scoringflexible compounds which are sterically capable of docking into a rigid conformation of the receptor. The three dimensional structures of a carefully chosen set of 300 pharmaceutically relevant protein-ligand complexes were used for the comparative study. The results show that Surflex outperforms largely Arguslab in all tests studied.

0 0
 · 
0 Bookmarks
 · 
84 Views
  • Article: Butyrylcholinesterase in metabolic syndrome.
    [show abstract] [hide abstract]
    ABSTRACT: Butyrylcholinesterase may have a role in a number of metabolic functions and could affect the expression of insulin resistance syndrome. We present our integrated work using clinical, biochemical and bioinformatic approaches to delineate the possible function of this enzyme. Initially, we constructed a phylogenic tree with nucleotides and amino acid sequences and showed the existence of similar sequences in bacteria, plants and in other animals. We also demonstrated a possible pathogenic role for BChE in the common existence of insulin resistance, type 2 diabetes and Alzheimer's disease by in silico method and followed it up with a diabetic mouse study where cognition was slowed along with changes in BChE levels. In the next group of in silico studies, we employed THEMATICS method to identify the amino acids at the active site and later performed docking studies with drugs. THEMATICS predicted two clusters of ionisable amino acid residues that are in proximity: one with two residues and another with 11 showed perturbation in the THEMATICS curves. Using ISIS/Draw 2.5SP4, ARGUSLAB 4.0.1 and HEX 5.1. software. 3-D ligands were docked with BChE motif (from PDB). We did not find any of the ligands studied with significant docking distance, indicating they did not have direct interaction with the active site. Subsequently we performed in silico studies to compare the secondary structure and domain of BChE. Protein-protein interaction showed the following intersections with BChE UBE21, CHAT, APOE, AATF, DF ALDH9A1, PDHX, PONI PSME3 and ATP6VOA2. The integrative physiological roles of proteins with poorly known functions can be approached by generating leads in silico, which can be studied in vivo, setting into movement an iterative process.
    Medical Hypotheses 12/2010; 75(6):648-51. · 1.39 Impact Factor

Full-text

View
10 Downloads
Available from

Keywords

300 pharmaceutically relevant protein-ligand complexes
 
Arguslab
 
diverse data
 
docking
 
docking programs
 
functions
 
lead discovery
 
molecular docking
 
pharmaceutical industry
 
pharmaceutically interesting targets
 
Planaria Software
 
rigid conformation
 
scoringflexible compounds
 
Structure-based lead optimization approaches
 
tests
 
three dimensional structures
 
used approach
 
virtual database screening
 
Virtual screening